Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Adaptive Biotechnologies: Q2 Earnings Snapshot AP - Wed Jul 29, 3:41PM CDT

Adaptive Biotechnologies: Q2 Earnings Snapshot

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results GlobeNewswire - Wed Jul 29, 3:05PM CDT

SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies Reports Tomorrow With Minimal Residual Disease Growth Already Priced In Barchart - Tue Jul 28, 4:01PM CDT

Barchart Research What to Expect from ADPT Earnings ADPT Generated July 28, 2026 Current Price $22.52 EPS Estimate $$-0.13 Consensus Rating Strong Buy Average Move 8.74% Adaptive Biotechnologies Reports...

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 GlobeNewswire - Thu Jul 9, 3:05PM CDT

SEATTLE, July 09, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering GlobeNewswire - Wed Jun 17, 5:00AM CDT

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of 100% and to repurchase...

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses GlobeNewswire - Mon Jun 15, 3:10PM CDT

SEATTLE, June 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company focused on translating the genetics of the adaptive immune system...

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering GlobeNewswire - Mon Jun 15, 3:05PM CDT

Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of at least 75% and to...

ADPT : 22.57 (-6.66%)
MarketBeat.com
Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference MarketBeat - Wed Jun 3, 5:04PM CDT

Adaptive Biotechnologies (NASDAQ:ADPT) Chief Executive Officer and Co-Founder Chad Robins said the company is focused on expanding its minimal residual disease testing business while pursuing targeted...

ADPT : 22.57 (-6.66%)
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research GlobeNewswire - Fri May 29, 6:30AM CDT

SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 22.57 (-6.66%)
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences GlobeNewswire - Thu May 21, 3:17PM CDT

SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 22.57 (-6.66%)

Barchart Exclusives

Apple vs. HP: The $5 Trillion Giant, or the Stock That Pays 15x the Dividend. Barchart - Fri Jul 31, 6:00PM CDT
One dominates in size and growth, but the other trades at a lower valuation and higher yield. Discover which is the better dividend stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.